Literature DB >> 9892057

Normative data for the Mattis Dementia Rating Scale.

J A Lucas1, R J Ivnik, G E Smith, D L Bohac, E G Tangalos, E Kokmen, N R Graff-Radford, R C Petersen.   

Abstract

Age-adjusted normative data are presented for persons over age 55 on the Mattis Dementia Rating Scale. Additional adjustment for the effect of education on test performance is also provided. These data were collected as part of Mayo's Older Americans Normative Studies (MOANS) in a continuing effort to develop age-appropriate norms for older persons on commonly used neuropsychological tests. The normative data presented here should prove more useful in characterizing the presence and severity of general cognitive dysfunction than currently available norms. Limitations and unique features of MOANS normative data are also discussed.

Entities:  

Mesh：

Year:  1998        PMID： 9892057     DOI： 10.1076/jcen.20.4.536.1469

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN： 1380-3395            Impact factor:   2.475


  66 in total

1.  Sentence processing in Lewy body spectrum disorder: the role of working memory.

Authors:  Rachel G Gross; Corey T McMillan; Keerthi Chandrasekaran; Michael Dreyfuss; Sharon Ash; Brian Avants; Philip Cook; Peachie Moore; David J Libon; Andrew Siderowf; Murray Grossman
Journal:  Brain Cogn       Date:  2012-01-02       Impact factor: 2.310

2.  Screening for DSM-IV-TR cognitive disorder NOS in Parkinson's disease using the Mattis Dementia Rating Scale.

Authors:  Gregory M Pontone; Justin Palanci; James R Williams; Susan Spear Bassett
Journal:  Int J Geriatr Psychiatry       Date:  2012-05-24       Impact factor: 3.485

3.  The organization and anatomy of narrative comprehension and expression in Lewy body spectrum disorders.

Authors:  Sharon Ash; Sharon X Xie; Rachel Goldmann Gross; Michael Dreyfuss; Ashley Boller; Emily Camp; Brianna Morgan; Jessica O'Shea; Murray Grossman
Journal:  Neuropsychology       Date:  2012-02-06       Impact factor: 3.295

4.  Amygdala network dysfunction in late-life depression phenotypes: Relationships with symptom dimensions.

Authors:  Wenjun Li; B Douglas Ward; Chunming Xie; Jennifer L Jones; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas
Journal:  J Psychiatr Res       Date:  2015-09-09       Impact factor: 4.791

5.  The Role of Stress as a Risk Factor for Progressive Supranuclear Palsy.

Authors:  Kristen D Kelley; Guerry Peavy; Steven Edland; Whitney Rogers; David E Riley; Yvette Bordelon; David Standaert; Stephen G Reich; Irene Litvan
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

6.  Hippocampal atrophy relates to fluid intelligence decline in the elderly.

Authors:  Aaron Reuben; Adam M Brickman; Jordan Muraskin; Jason Steffener; Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2010-11-24       Impact factor: 2.892

7.  Health risk prediction models incorporating personality data: Motivation, challenges, and illustration.

Authors:  Benjamin P Chapman; Feng Lin; Shumita Roy; Ralph H B Benedict; Jeffrey M Lyness
Journal:  Personal Disord       Date:  2019-01

8.  Semantic memory activation in amnestic mild cognitive impairment.

Authors:  J L Woodard; M Seidenberg; K A Nielson; P Antuono; L Guidotti; S Durgerian; Q Zhang; M Lancaster; N Hantke; A Butts; S M Rao
Journal:  Brain       Date:  2009-06-10       Impact factor: 13.501

9.  The co-existence of geriatric depression and amnestic mild cognitive impairment detrimentally affect gray matter volumes: voxel-based morphometry study.

Authors:  Chunming Xie; Wenjun Li; Gang Chen; B Douglas Ward; Malgorzata B Franczak; Jennifer L Jones; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas
Journal:  Behav Brain Res       Date:  2012-08-14       Impact factor: 3.332

10.  Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.

Authors:  D Aarsland; I Litvan; D Salmon; D Galasko; T Wentzel-Larsen; J P Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.